EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fentanyl–Antibody Interaction as a Novel Strategy against Opiates and Opioids Abuse

Giovanni Ribaudo iD, Andrea Achille Taccani, Alessandra Gianoncelli iD

Journal of Medicinal Chemistry · 24.04.2025 · 68 (8) · 7866-7888

DOI: 10.1021/acs.jmedchem.4c02860 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.04.2025. Verfasst von Giovanni Ribaudo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Fentanyl, Opioid-Related Disorders, Analgesics, Opioid, Antibodies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universit? degli Studi di Brescia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While naloxone remains the antidote for opioid overdoses, more efficient tools are required to effectively combat this growing crisis. Vaccines and antibodies targeting substances of abuse appear to be a novel and promising approach to tackling the fentanyl and opioid epidemic. After an initial in-depth rundown on the pharmacodynamics of the substances involved from a structural and mechanistic standpoint, and a brief overview of pharmacological approaches used in clinical settings for managing overdoses and opioid addiction, this Perspective will be mainly focused on these innovative strategies, based on the development of antibodies binding and sequestering substances of abuse and on their generation in vivo through vaccines. The most promising approaches will be examined, from production techniques to their potential clinical applications, analyzing the structures and mechanisms of antibody-substance interactions and comparing these with receptor binding processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylOpioid-Related DisordersAnalgesics, OpioidAntibodiesHumansAnimals

Substanzen

FentanylAnalgesics, OpioidAntibodies

Autor:innen und Institutionen

  • Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.

ORCID-Profile: Giovanni Ribaudo, Alessandra Gianoncelli

Förderung

  • Universit? degli Studi di Brescia

Zitieren

APA

Ribaudo, G., Taccani, A. A., & Gianoncelli, A. (2025). Fentanyl–Antibody Interaction as a Novel Strategy against Opiates and Opioids Abuse. Journal of Medicinal Chemistry, 68(8), 7866-7888. https://doi.org/10.1021/acs.jmedchem.4c02860

Vancouver

Ribaudo G, Taccani AA, Gianoncelli A. Fentanyl–Antibody Interaction as a Novel Strategy against Opiates and Opioids Abuse. Journal of Medicinal Chemistry. 2025;68(8):7866-7888. doi:10.1021/acs.jmedchem.4c02860

BibTeX
@article{Ribaudo2025,
  author = {Ribaudo, Giovanni and Taccani, Andrea Achille and Gianoncelli, Alessandra},
  title = {Fentanyl–Antibody Interaction as a Novel Strategy against Opiates and Opioids Abuse},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {8},
  pages = {7866--7888},
  doi = {10.1021/acs.jmedchem.4c02860}
}
Kostenlos starten →